keyword
MENU ▼
Read by QxMD icon Read
search

Siderophore cephalosporin

keyword
https://www.readbyqxmd.com/read/27874971/cefiderocol-a-siderophore-cephalosporin-for-gram-negative-bacterial-infections-pharmacokinetics-and-safety-in-subjects-with-renal-impairment
#1
Takayuki Katsube, Roger Echols, Juan Camilo Arjona Ferreira, Heidi K Krenz, Jolene Kay Berg, Christopher Galloway
Cefiderocol, a new injectable siderophore cephalosporin antibiotic, has promising in vitro and in vivo activity against Gram-negative bacteria including multidrug-resistant Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. Cefiderocol is mainly renally eliminated. The pharmacokinetics and safety of cefiderocol in subjects with renal impairment were assessed following a single 1000-mg intravenous 1-hour infusion of cefiderocol. Subjects with mild, moderate, or severe renal impairment and end-stage renal disease (ESRD) requiring hemodialysis were compared with demographically (age, body mass index, and sex) matched healthy subjects with normal renal function...
November 22, 2016: Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/27795374/pharmacokinetic-pharmacodynamic-modeling-and-simulation-of-cefiderocol-a-parenteral-siderophore-cephalosporin-for-dose-adjustment-based-on-renal-function
#2
Takayuki Katsube, Toshihiro Wajima, Toru Ishibashi, Juan Camilo Arjona Ferreira, Roger Echols
The novel parenteral siderophore cephalosporin, cefiderocol, exhibits potent efficacy against most Gram-negative bacteria including carbapenem-resistant strains. Since cefiderocol is primarily excreted via the kidneys, this study was conducted to develop a population pharmacokinetic (PK) model to determine dose adjustment based on renal function.Population PK models were developed based on cefiderocol concentration data in plasma, urine and dialysate with a non-linear mixed effects model approach. Monte-Carlo simulations were conducted to calculate the probability of target attainment (PTA) of fraction of time during the dosing interval where the free drug concentration in plasma exceeds the minimum inhibitory concentration (MIC) (Tf>MIC) for a MIC range of 0...
October 17, 2016: Antimicrobial Agents and Chemotherapy
https://www.readbyqxmd.com/read/27736756/siderophore-cephalosporin-cefiderocol-utilizes-ferric-iron-transporter-systems-for-antibacterial-activity-against-pseudomonas-aeruginosa
#3
Akinobu Ito, Toru Nishikawa, Shuhei Matsumoto, Hidenori Yoshizawa, Takafumi Sato, Rio Nakamura, Masakatsu Tsuji, Yoshinori Yamano
Cefiderocol (S-649266) is a novel parenteral siderophore cephalosporin conjugated with a catechol moiety at the 3(rd)-position side chain. The in vitro activity of cefiderocol against Pseudomonas aeruginosa was enhanced in the iron-depleted condition where that of ceftazidime was not affected. The monitoring of [Thiazole-(14)C]-cefiderocol revealed the increased intracellular accumulation of cefiderocol in the P. aeruginosa cells incubated under iron-depleted condition compared with those incubated under iron-sufficient condition...
October 10, 2016: Antimicrobial Agents and Chemotherapy
https://www.readbyqxmd.com/read/27512687/imaging-bacteria-with-radiolabelled-quinolones-cephalosporins-and-siderophores-for-imaging-infection-a-systematic-review
#4
S Auletta, F Galli, C Lauri, D Martinelli, I Santino, Alberto Signore
Bacterial infections are still one of the main causes of patient morbidity and mortality worldwide. Nowadays, many imaging techniques, like computed tomography or magnetic resonance imaging, are used to identify inflammatory processes, but, although they recognize anatomical modifications, they cannot easily distinguish bacterial infective foci from non bacterial infections. In nuclear medicine, many efforts have been made to develop specific radiopharmaceuticals to discriminate infection from sterile inflammation...
2016: Clinical and Translational Imaging: Reviews in Nuclear Medicine and Molecular Imaging
https://www.readbyqxmd.com/read/27139465/stability-of-novel-siderophore-cephalosporin-s-649266-against-clinically-relevant-carbapenemases
#5
Tsukasa Ito-Horiyama, Yoshikazu Ishii, Akinobu Ito, Takafumi Sato, Rio Nakamura, Norio Fukuhara, Masakatsu Tsuji, Yoshinori Yamano, Keizo Yamaguchi, Kazuhiro Tateda
To better understand the antibacterial activity of S-649266 against carbapenemase producers, its stability against clinically relevant carbapenemases was investigated. The catalytic efficiencies (kcat/Km) of IMP-1, VIM-2, and L1 for S-649266 were 0.0048, 0.0050, and 0.024 μM(-1) s(-1), respectively, which were more than 260-fold lower than that for meropenem. Only slight hydrolysis of S-649266 against KPC-3 was observed. NDM-1 hydrolyzed meropenem 3-fold faster than S-649266 at 200 μM.
July 2016: Antimicrobial Agents and Chemotherapy
https://www.readbyqxmd.com/read/27025519/microarray-evaluation-of-antimicrobial-resistance-and-virulence-of-escherichia-coli-isolates-from-portuguese-poultry
#6
Nuno Mendonça, Rui Figueiredo, Catarina Mendes, Roderick M Card, Muna F Anjum, Gabriela Jorge da Silva
The presence of antimicrobial resistance and virulence factors of 174 Escherichia coli strains isolated from healthy Portuguese Gallus gallus was evaluated. Resistance profiles were determined against 33 antimicrobials by microbroth dilution. Resistance was prevalent for tetracycline (70%) and ampicillin (63%). Extended-spectrum beta-lactamase (ESBL) phenotype was observed in 18% of the isolates. Multidrug resistance was found in 56% of isolates. A subset of 74 isolates were screened by DNA microarrays for the carriage of 88 antibiotic resistance genes and 62 virulence genes...
2016: Antibiotics
https://www.readbyqxmd.com/read/26645269/in-vitro-antimicrobial-activity-of-s-649266-a-catechol-substituted-siderophore-cephalosporin-when-tested-against-non-fermenting-gram-negative-bacteria
#7
COMPARATIVE STUDY
Akinobu Ito, Naoki Kohira, Samuel K Bouchillon, Joshua West, Stephen Rittenhouse, Helio S Sader, Paul R Rhomberg, Ronald N Jones, Hidenori Yoshizawa, Rio Nakamura, Masakatsu Tsuji, Yoshinori Yamano
OBJECTIVES: S-649266 is a parenteral siderophore cephalosporin antibiotic with a catechol moiety on its side chain. The in vitro antimicrobial activity of S-649266 against non-fermenting Gram-negative bacteria was evaluated and compared with the activities of meropenem, levofloxacin, cefepime, ceftazidime and piperacillin/tazobactam. METHODS: MIC values of S-649266 were determined in Mueller-Hinton broth or Iso-Sensitest broth supplemented with apo-transferrin. RESULTS: S-649266 showed potent in vitro activity against the non-fermenting Gram-negative bacteria Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia, including MDR strains such as carbapenem-resistant A...
March 2016: Journal of Antimicrobial Chemotherapy
https://www.readbyqxmd.com/read/26574013/in-vitro-antimicrobial-activity-of-a-siderophore-cephalosporin-s-649266-against-enterobacteriaceae-clinical-isolates-including-carbapenem-resistant-strains
#8
Naoki Kohira, Joshua West, Akinobu Ito, Tsukasa Ito-Horiyama, Rio Nakamura, Takafumi Sato, Stephen Rittenhouse, Masakatsu Tsuji, Yoshinori Yamano
S-649266 is a novel siderophore cephalosporin antibiotic with a catechol moiety on the 3-position side chain. Two sets of clinical isolate collections were used to evaluate the antimicrobial activity of S-649266 against Enterobacteriaceae. These sets included 617 global isolates collected between 2009 and 2011 and 233 β-lactamase-identified isolates, including 47 KPC-, 49 NDM-, 12 VIM-, and 8 IMP-producers. The MIC90 values of S-649266 against the first set of Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, Citrobacter freundii, Enterobacter aerogenes, and Enterobacter cloacae isolates were all ≤1 μg/ml, and there were only 8 isolates (1...
February 2016: Antimicrobial Agents and Chemotherapy
https://www.readbyqxmd.com/read/25622119/iron-limitation-enhances-acyl-homoserine-lactone-ahl-production-and-biofilm-formation-in-clinical-isolates-of-acinetobacter-baumannii
#9
Farzan Modarresi, Omid Azizi, Mohammad Reza Shakibaie, Mohammad Motamedifar, Ellahe Mosadegh, Shahla Mansouri
Acinetobacter baumannii is an important source of infections in intensive care units (ICUs) of our hospitals in Kerman, Iran and the most frequently isolated strains produce biofilm. There is a little information about role of iron (Fe) levels on acyl homoserine lactone (AHL) production and biofilm formation in this microorganism. In the present study, we investigated the influence of iron-III limitation on AHL, siderophore, catechol and virulence factors in the biofilm forming clinical strains of A. baumannii...
2015: Virulence
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"